Biglycan Is Required for Adaptive Remodeling After Myocardial Infarction
Author(s) -
Dirk Westermann,
Jan Mersmann,
A. Melchior,
Till Freudenberger,
Christian Petrik,
Liliana Schaefer,
Renate LüllmannRauch,
Olga Lettau,
Christoph Jacoby,
Jürgen Schrader,
StefanMartin BrandHerrmann,
Marian F. Young,
HeinzPeter Schultheiß,
Bodo Levkau,
Hideo A. Baba,
T Unger,
Kai Zacharowski,
Carsten Tschöpe,
Jens W. Fischer
Publication year - 2008
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.107.714147
Subject(s) - biglycan , medicine , hemodynamics , cardiology , ventricular remodeling , myocardial infarction , diastole , blood pressure , anatomy , decorin , proteoglycan , cartilage
After myocardial infarction (MI), extensive remodeling of extracellular matrix contributes to scar formation and preservation of hemodynamic function. On the other hand, adverse and excessive extracellular matrix remodeling leads to fibrosis and impaired function. The present study investigates the role of the small leucine-rich proteoglycan biglycan during cardiac extracellular matrix remodeling and cardiac hemodynamics after MI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom